These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8070509)

  • 1. Renal clearance of lomefloxacin is decreased by furosemide.
    Sudoh T; Fujimura A; Shiga T; Sasaki M; Harada K; Tateishi T; Ohashi K; Ebihara A
    Eur J Clin Pharmacol; 1994; 46(3):267-9. PubMed ID: 8070509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ranitidine on renal clearance of lomefloxacin.
    Sudoh T; Fujimura A; Harada K; Sunaga K; Ohmori M; Sakamoto K
    Eur J Clin Pharmacol; 1996; 51(1):95-8. PubMed ID: 8880059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function.
    Nilsen OG; Saltvedt E; Walstad RA; Marstein S
    Am J Med; 1992 Apr; 92(4A):38S-40S. PubMed ID: 1316068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of probenecid and ranitidine on urinary excretion of lomefloxacin in rats.
    Sasaki M; Fujimura A
    Jpn J Pharmacol; 1996 Jul; 71(3):263-4. PubMed ID: 8854210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones].
    Iakovlev VP
    Antibiot Khimioter; 1998; 43(10):46-52. PubMed ID: 9825111
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA
    Am J Med; 1992 Apr; 92(4A):18S-21S. PubMed ID: 1316065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lomefloxacin clinical pharmacokinetics.
    Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
    Clin Pharmacokinet; 1993 Jul; 25(1):6-19. PubMed ID: 8394795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics.
    Stuht H; Lode H; Koeppe P; Rost KL; Schaberg T
    Antimicrob Agents Chemother; 1995 May; 39(5):1045-9. PubMed ID: 7625786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and safety of single oral doses of lomefloxacin.
    Morse IS
    Biopharm Drug Dispos; 1990; 11(6):543-51. PubMed ID: 2207304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of lomefloxacin in patients with cirrhosis.
    Lebrec D; Gaudin C; Benhamou JP
    Am J Med; 1992 Apr; 92(4A):41S-44S. PubMed ID: 1316069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of lomefloxacin in renally compromised patients.
    Blum RA; Schultz RW; Schentag JJ
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2364-8. PubMed ID: 2088191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.
    Morrison PJ; Mant TG; Norman GT; Robinson J; Kunka RL
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1503-7. PubMed ID: 3214495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.
    Wijnands GJ; Cornel JH; Martea M; Vree TB
    Chest; 1990 Dec; 98(6):1440-4. PubMed ID: 2245687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Leroy A; Fillastre JP; Humbert G
    Antimicrob Agents Chemother; 1990 Jan; 34(1):17-20. PubMed ID: 2327756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid.
    Staib AH; Harder S; Fuhr U; Wack C
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):289-3. PubMed ID: 2737798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
    Kovarik JM; Hoepelman AI; Smit JM; Sips PA; Rozenberg-Arska M; Glerum JH; Verhoef J
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2458-61. PubMed ID: 1336948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of products containing metal ions on the absorption of lomefloxacin.
    Lehto P; Kivistö KT
    Clin Pharmacol Ther; 1994 Nov; 56(5):477-82. PubMed ID: 7955811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of bioequivalence of lomefloxacin tablets using urinary excretion data.
    Shah SA; Rathod IS; Savale SS; Patel DB
    J Pharm Biomed Anal; 2002 Nov; 30(4):1319-29. PubMed ID: 12408922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of interaction between lomefloxacin and caffeine in normal volunteers.
    Healy DP; Schoenle JR; Stotka J; Polk RE
    Antimicrob Agents Chemother; 1991 Apr; 35(4):660-4. PubMed ID: 2069371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.
    Bergogne-Bérézin E; Muller-Serieys C; Kafé H
    Am J Med; 1992 Apr; 92(4A):8S-11S. PubMed ID: 1316076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.